Brain metabolism predicts survival in advanced non–small cell lung cancer patients
Low brain metabolism as measured by ¹⁸F-FDG PET/CT is associated with higher mortality in patients with advanced non-small cell lung cancer (NSCLC), according to new research published in The Journal of Nuclear Medicine. Incorporating brain ¹⁸F-FDG uptake alongside clinical, tumor and biological dat
<p>Low brain metabolism as measured by ¹⁸F-FDG PET/CT is associated with higher mortality in patients with advanced non-small cell lung cancer (NSCLC), according to new research published in The Journal of Nuclear Medicine. Incorporating brain ¹⁸F-FDG uptake alongside clinical, tumor and biological dat</p>